Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1360 of 6351
-
Could earlier breathing help in ALS? new trial aims to find out
Disease control Recruiting nowAmyotrophic lateral sclerosis (ALS) is a disease that causes weakness of the muscles of the body. The disease can eventually lead to severe breathing problems, which is the most common cause of death from ALS. The treatment for breathing is non-invasive ventilation (NIV). It is a…
Phase 2 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Bacteria in the mouth and gut may predict who responds to cancer immunotherapy
Knowledge-focused Recruiting nowThis is a prospective observational cohort study conducted at Fundación CTIC in Bogotá, Colombia. It characterizes the oral, fecal and intratumoral microbiome of Colombian adults with advanced solid tumors (gastric, colorectal, breast, cervical and head-and-neck cancer) who recei…
Sponsor: Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC
-
New pill aims to fight Obesity-Linked inflammation
Disease control Recruiting nowThe purpose of this study is to learn about the effects of BGE-102 on blood biomarkers including hsCRP, which is a lab value used to measure inflammation. BGE-102 decreases inflammation which may improve obesity and cardiovascular health. Participants will receive either BGE-102 …
Phase 2 • Sponsor: BioAge Labs, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New oral drug INT-210 aims to tame ulcerative colitis Flare-Ups
Disease control Recruiting nowA Multicenter, Randomized, Open-label Clinical Study to Evaluate the Safety and Efficacy of INT-210 Capsules in Participants with Active Ulcerative Colitis. The study aims to evaluate the safety, efficacy, pharmacokinetic (PK) characteristics, pharmacodynamic (PD) characteristic…
Phase 1/2 • Sponsor: Innatus Therapeutics (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
New drug senaparib tested in Real-World ovarian cancer study
Disease control Not yet recruitingOvarian cancer is one of the most fatal malignant tumors that threaten women's health. The incidence rate is the third place among the female reproductive system malignant tumors, and the mortality rate ranks the first in gynecologic malignancies, the majority of patients have ad…
Sponsor: Zhejiang Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New acid reducer shows promise in fighting stomach bug
Disease control Not yet recruitingThis is a multicenter, randomized, double blind, double-simulated, parallel control of positive drug phase III clinical study to evaluate the efficacy and safety of Anaprazole versus Esomeprazole-containing Bismuth quadruple therapy for eradication of Helicobacter pylori in China…
Phase 3 • Sponsor: Xuanzhu Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Freeze or zap? new trial tests Drug-Free pain relief for stubborn knee arthritis
Symptom relief Recruiting nowThe project will evaluate the effectiveness of Cryoneurolysis versus radiofrequency procedures in adult patients who are resistant to traditional treatment for knee pain. They are a drug-free pain management procedure.
Sponsor: Tanta University • Aim: Symptom relief
Last updated Aug 13, 2026 00:00 UTC
-
Inhaled mRNA therapy takes on solid tumors in first human trial
Disease control Not yet recruitingThis is an open-label phase I master platform study to evaluate the safety, tolerability and preliminary anti-tumor efficacy of multiple inhaled in-vivo mRNA immunotherapies in adult patients with advanced solid tumors. Subjects will receive inhalation mRNA formulations at ascend…
Early phase 1 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug cocktail aims to tackle tough lymphoma
Disease control Not yet recruitingAssess the efficacy and safety of glofitamab in combination with selinexor for the treatment of relapsed or refractory diffuse large B-cell lymphoma (R/R DLBCL) in patients who have received at least two prior lines of systemic therapy.
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Scientists map cognitive profiles in rare brain disorder to personalize rehabilitation
Knowledge-focused Recruiting nowThe goal of this observational study is to learn about the neuropsychological profile of Sturge-Weber Syndrome (SWS) in children and adults with this rare neurocutaneous condition. SWS affects approximately 1 in 50,000 live births and is characterized by brain blood vessel malfor…
Sponsor: University of Roma La Sapienza • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Can a 4-Week online course ease student stress and anxiety?
Symptom relief Recruiting nowThe mental health of university students requires urgent attention, as many students are exposed to increased risk of psychological distress, including symptoms of depression, anxiety, academic stress, and reduced well-being. Although many students experience mental health diffic…
Sponsor: University of Bologna • Aim: Symptom relief
Last updated Aug 29, 2026 00:00 UTC
-
Could removing preservatives from glaucoma drops save Patients' eyes?
Disease control OngoingThe primary objective of this study is to evaluate the ocular surface safety of an ophthalmic solution indicated for the management of glaucoma, containing the active ingredients dorzolamide, timolol, and brimonidine, in patients diagnosed with primary open-angle glaucoma. The mo…
Phase 4 • Sponsor: Tecnoquimicas • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Tendon pain showdown: which injection works better?
Disease control Recruiting nowChronic tendinopathies and enthesopathies are common musculoskeletal conditions in orthopedics and sports medicine, frequently leading to pain, impaired function, and significantly reduced quality of life. Their pathogenesis involves tissue degeneration and ineffective repair res…
Sponsor: Ortonika Orthopedic Medical Clinic in Lublin • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Mind over scalpel: could guided breathing replace sedatives during eye surgery?
Symptom relief Recruiting nowThis randomized controlled trial evaluates whether a standardized perioperative neuroplastic intervention: the STEIN Protocol (Strategies and Techniques for Enhancing Integration and Neuroplasticity), consisting of pain neuroscience education, guided imagery, and paced breathing,…
Sponsor: University of California, Los Angeles • Aim: Symptom relief
Last updated Jul 25, 2026 00:00 UTC
-
Blood test score may flag High-Risk esophageal surgery patients
Knowledge-focused CompletedEsophagectomy is associated with substantial postoperative morbidity despite advances in perioperative care. The Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP) score has been proposed as a composite biomarker reflecting nutritional, inflammatory, and immune status; however,…
Sponsor: Istanbul Saglik Bilimleri University • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
Freezing tumors before chemo: new hope for esophageal cancer?
Disease control Recruiting nowThis research study is for people who have locally advanced esophageal adenocarcinoma and are expected to receive chemotherapy. The purpose of this study is to compare the effectiveness of Liquid Nitrogen Spray Cryotherapy (LNSC) in addition to chemotherapy versus chemotherapy al…
Phase 2 • Sponsor: Case Comprehensive Cancer Center • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Could a Sea-Shell pad replace the sandbag after heart procedures?
Disease control Recruiting nowThe aim of this study is to compare bleeding outcomes, pain, comfort levels, sleep quality, and associated factors among patients receiving a chitosan-based hemostatic pad versus a sandbag following femoral coronary angiography (CAG) and percutaneous coronary intervention (PCI). …
Sponsor: Uludag University • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
New trial aims to outsmart drug resistance in colorectal cancer
Disease control Not yet recruitingTo find out if certain drug/therapy combinations that are targeted to individual patients based on characteristics of their disease types may help to control the disease.
Early phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Eye movement therapy without painful recall shows promise for PTSD
Symptom relief Recruiting nowIntrusive traumatic memories frequently trigger severe distress and psychological disorders such as post-traumatic stress disorder (PTSD). Traditional therapies require explicit trauma recall, which often causes severe patient distress and may lead to treatment avoidance. To addr…
Sponsor: Zhu Zijian • Aim: Symptom relief
Last updated Sep 04, 2026 00:00 UTC
-
New hope for kidney cancer patients with bone spread: drug combo trial launches
Disease control Recruiting nowThis is a single-institution, phase 2 trial of zanzalintinib plus investigator-choice bone-strengthening agent in patients with metastatic renal cell carcinoma (RCC) with bone metastases whose disease has advanced on 1-3 prior lines of therapy, including at least one immune oncol…
Phase 2 • Sponsor: Kelly Fitzgerald, MD • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC